Neurocrine Biosciences
NBIX
#1380
Rank
A$23.12 B
Marketcap
A$231.91
Share price
-0.65%
Change (1 day)
14.95%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2025 (TTM): A$0.90 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are A$2.68 Billion. In 2024 the company made an earning of A$0.92 Billion, an increase over its 2023 earnings that were of A$0.46 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.90 B-2.24%
2024 A$0.92 B96.41%
2023 A$0.46 B41.13%
2022 A$0.33 B73.74%
2021 A$0.19 B-8.82%
2020 A$0.21 B77.78%
2019 A$0.11 B49.83%
2018 A$78.87 M-142.57%
2017 -A$0.19 Billion-14.73%
2016 -A$0.22 Billion53.15%
2015 -A$0.15 Billion46.25%
2014 -A$97.01 Million29.66%
2013 -A$74.83 Million-3530.8%
2012 A$2.18 M-95.73%
2011 A$51.08 M
2009 -A$71.82 Million-45.38%
2008 -A$0.14 Billion-58.87%
2007 -A$0.32 Billion87.3%
2006 -A$0.18 Billion351.97%
2005 -A$37.77 Million-52.09%
2004 -A$78.83 Million-10.98%
2003 -A$88.54 Million
2001 -A$66.1 Million
1999 -A$29.81 Million108.32%
1998 -A$14.31 Million
1996 A$4.36 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Repligen
RGEN
A$39.37 M-95.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
A$2.38 B 171.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Palatin Technologies
PTN
-A$26.05 Million-102.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$33.89 B 3,758.64%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$2.50 B 184.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$17.85 B 1,932.24%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
A$76.13 M-91.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-A$62.9 Million-107.16%๐Ÿ‡บ๐Ÿ‡ธ USA